Stock Monitor: AngioDynamics Post Earnings Reporting
LONDON, UK / ACCESSWIRE / April 05, 2018 / Active-Investors.com has just released a free research report on Waters Corp. (NYSE: WAT). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=WAT as the Company's latest news hit the wire. On April 03, 2018, the Company announced that it plans to significantly expand its precision chemistry operation in Taunton, Massachusetts. The Company will invest approximately $215 million to build and equip a new state-of-the-art facility that will support rising global customer demand as well as ongoing innovation in chemistry technology. Register today and get access to over 1,000 Free Research Reports by joining our site below:
www.active-investors.com/registration-sg
Active-Investors.com is currently working on the research report for AngioDynamics, Inc. (NASDAQ: ANGO), which also belongs to the Healthcare sector as the Company Waters. Do not miss out and become a member today for free to access this upcoming report at:
www.active-investors.com/registration-sg/?symbol=ANGO
Active-Investors.com is focused on giving you timely information and the inside line on companies that matter to you. This morning, Waters most recent news is on our radar and our team decided to put out a fantastic report on the company that is now available for free below:
www.active-investors.com/registration-sg/?symbol=WAT
Waters' Taunton site is responsible for bulk synthesis of chromatographic media which is critical to sample analysis for pharmaceutical, biopharmaceutical, materials, food, clinical and biomedical research applications.
Details of the New Facility
- The Company plans to employ LEED certification standards as well as state-of-the-art manufacturing and process technology to construct a new center-of-excellence that meets output, cost, quality, and sustainability objectives.
- Waters expects the new plant will be operational by 2022. Until then, the existing Taunton facility will fully meet operational and growth needs.
- The return on this investment will be enhanced by the Company's access to capital following US tax reform as well as the strong partnership of the Commonwealth of Massachusetts and the City of Taunton.
- The Taunton project is a noteworthy example of Waters' capital allocation strategy, which prioritizes investing for long-term growth and innovation.
Taunton Facility Will Ensure Customers Continue to Benefit from the Most Innovative Chromatography Particle R&D
Christopher J. O'Connell, Chairman and Chief Executive Officer of Waters Corp., stated that the Company's portfolio of innovative precision chemistry products is critical to scientific advancements in the life, materials, and food sciences. Christopher added that the expansion of Waters' Taunton facility will ensure the customers continue to benefit from the most innovative chromatography particle R&D and the highest quality production in the industry.
Waters Corp. Introduced New ACQUITY™ Arc™ Bio System
On January 30, 2018, Waters introduced the Waters® ACQUITY™ Arc™ Bio System, a versatile, iron-free, bio-inert, quaternary liquid chromatograph specifically engineered to enable the efficient transfer and improvement of bioseparation analytical methods regardless of the LC platform on which the original method was developed. Since its 2015 launch, the original ACQUITY™ Arc™ System has become a workhorse of pharmaceutical development and QC laboratories throughout the world. With the introduction of the ACQUITY™ Arc™ Bio System, biopharmaceutical laboratories could take advantage of the power of the ACQUITY™ Arc™ platform for creating robust and reliable methods that could be transferred easily from lab-to-lab and from one LC instrument platform to another without compromising method integrity.
About Waters Corp.
Waters Corp., the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for nearly 60 years. The Company designs, manufactures, sells and services analytical technologies: liquid chromatography, mass spectrometry, and thermal analysis. Headquartered in Milford, Massachusetts, Waters Corp. operates directly in 31 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.
Stock Performance Snapshot
April 04, 2018 - At Wednesday's closing bell, Waters' stock climbed 1.41%, ending the trading session at $201.62.
Volume traded for the day: 549.10 thousand shares, which was above the 3-month average volume of 510.83 thousand shares.
Stock performance in the last month – up 0.12%; previous three-month period – up 3.03%; past twelve-month period – up 28.67%; and year-to-date - up 4.36%
After yesterday's close, Waters' market cap was at $16.03 billion.
Price to Earnings (P/E) ratio was at 28.37.
The stock is part of the Healthcare sector, categorized under the Medical Instruments & Supplies industry. This sector was up 1.4% at the end of the session.
Active-Investors:
Active-Investors (A-I) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. A-I has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
A-I has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@active-investors.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by A-I. A-I is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
A-I, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. A-I, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, A-I, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither A-I nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://active-investors.com/legal-disclaimer/.
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@active-investors.com
Phone number: 73 29 92 6381
Office Address: 6, Jalan Kia Peng, Kuala Lumpur, 50450 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Active-Investors
